Dexmedetomidine versus Haloperidol for Sedation of Non-intubated Patients with Hyperactive Delirium during the Night in a High Dependency Unit: an open-label, parallel-group, randomized controlled trial - DEX-HD trial

Ohtsuru Shigeru0 个研究点目标入组 100 人开始时间: 2022年4月23日最近更新: 2023年10月17日

试验速览

暂无简介。

•Non-intubated patients who are urgently admitted to the High Dependency Unit of the Department of Primary Care and Emergency Medicine or the Department of Cardiovascular Medicine at Kyoto University Hospital from the emergency room.

•Patients who have received non-invasive ventilation (NIV).
•Patients with tracheostomy.
•Patients who have already started to receive dexmedetomidine or haloperidol by bolus injection or drip infusion or intramuscular injection before admission to the High Dependency Unit.
•Patients with a diagnosis of schizophrenia or mania.
•Patients with contraindications to haloperidol or dexmedetomidine (e.g., allergy to any of the investigational drugs, prolonged QTc on electrocardiogram)
•Women who are pregnant or possibly pregnant, and women who are lactating..
•Patients who cannot understand Japanese
•Other patients who are judged by the principal investigator or sub-investigator to be inappropriate for this study.

发起方

Ohtsuru Shigeru